SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics. - Wikidata - awgldk - TriplyDB

SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.

SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.

http://www.wikidata.org/entity/Q33222839

about

A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass.Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Proteomics and ovarian cancer: integrating proteomics information into clinical care Proteomics as a guiding tool for more effective personalized therapy.An antibody-graphene oxide nanoribbon conjugate as a surface enhanced laser desorption/ionization probe with high sensitivity and selectivity.Graphene oxide nanoribbons: improved synthesis and application in MALDI mass spectrometry.Biomarker method validation in anticancer drug development Proteomic analysis of bone cancer: a review of current and future developments.Toward digital staining using imaging mass spectrometry and random forests.Technological Advancements in Mass Spectrometry and Its Impact on Proteomics

P2860

Q30528206-E9E425EB-9A12-47CA-B0A8-AE095EC03352 Q33467523-879CB29B-DEC5-4B91-AE24-640423E3157B Q34126627-528B6F9F-37A2-4F64-BDFB-F803A430690D Q34480451-095E1D09-ECBD-4A26-8479-77988544AC7B Q35562299-EA53C35C-F84E-4E12-B770-0850C5A5FDB4 Q35562850-0FB11A2A-FB3B-4D69-936E-48DBA7F0655A Q36484621-5CD38B0A-A5B9-48A7-A1E7-8EED4DC45323 Q36841875-A269F5D6-8BEF-46C1-B478-961AD1786B09 Q37390707-13F7BA26-F161-45AE-BFFC-74A7A716C3D2 Q58302428-378D8946-2EBA-4544-97F5-061A5267DDF3

P2860

SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.

http://www.wikidata.org/entity/Q33222839

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

SELDI-TOF mass spectrometry fo ...... d serum proteomic diagnostics.

@ast

SELDI-TOF mass spectrometry fo ...... d serum proteomic diagnostics.

@en

type

label

SELDI-TOF mass spectrometry fo ...... d serum proteomic diagnostics.

@ast

SELDI-TOF mass spectrometry fo ...... d serum proteomic diagnostics.

@en

prefLabel

SELDI-TOF mass spectrometry fo ...... d serum proteomic diagnostics.

@ast

SELDI-TOF mass spectrometry fo ...... d serum proteomic diagnostics.

@en

P1433

Q33222839-40453AC0-C756-4F9D-9AF3-AC08FE8F0C1D

P1476

Q33222839-190F4286-2E90-4C86-9B69-55E654EE753A

P2093

Q33222839-018A23D2-F5F9-4210-B48B-B07BE1361337

Q33222839-0E38FA50-F8AA-4ABB-90E0-3E514698AACA

Q33222839-8E38DF3F-253E-4A9F-9A1D-2480D5B6D6FA

Q33222839-F8AD6FDE-F3F4-4C7D-AF84-58EC51114C14

P2860

Q33222839-00A66868-ECA5-48FB-8BFD-B5699A0D89D0

Q33222839-0D73CDFE-5978-47C3-9F7F-053B677CDDD6

Q33222839-1010960D-C623-439D-B266-D7D621E6C3B7

Q33222839-17AF6213-C35F-43A4-A0BF-3CE2AEB9B644

Q33222839-1BCBA357-FED7-4007-BC11-B21241D8DFDF

Q33222839-1C99695A-FD1A-4971-B472-528FB365C702

Q33222839-2A77E4DF-90F2-4615-9CCD-83C4B48D9DE0

Q33222839-2F288324-F13F-4265-9FC4-FBD4A1B9E946

Q33222839-33E10122-3F63-4B3F-8912-5E8308DAAB3B

Q33222839-3A1BFCF6-0059-46F0-A107-1F5B923A302B

P304

Q33222839-3EC62E32-0582-4194-B5CD-AA4CF3D958D4

P31

Q33222839-271B9FB3-0845-40E1-BF3D-E16F16078F45

P356

Q33222839-117BACB1-B0C1-46B8-9E63-A285DB181623

P433

Q33222839-9FB747DF-FABF-4CBD-A7A7-44EE52984136

P478

Q33222839-86C1B96A-2B0F-4688-BC94-CE0BDE812F08

P577

Q33222839-C695FBAD-0F68-40A7-B8CB-A6EDB9BE0B03

P698

Q33222839-77019B83-1135-4715-A9D5-F2A96C9BF537

P921

Q33222839-EDA2792F-F924-46FE-8A93-26A40002C41E

P356

14622416.6.6.647

P1433

Pharmacogenomics

P1476

SELDI-TOF mass spectrometry fo ...... d serum proteomic diagnostics.

@en

P2093

Elise C Kohn

http://www.w3.org/2001/XMLSchema#string

Fiona Simpkins

http://www.w3.org/2001/XMLSchema#string

Josephine A Czechowicz

http://www.w3.org/2001/XMLSchema#string

Lance Liotta

http://www.w3.org/2001/XMLSchema#string

P2860

The human plasma proteome: a nonredundant list developed by combination of four separate sources

Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data

An Automated Peak Identification/Calibration Procedure for High-Dimensional Protein Measures From Mass Spectrometers

A data review and re-assessment of ovarian cancer serum proteomic profiling

Oncogenic kinase signalling

Use of serological proteomic methods to find biomarkers associated with breast cancer

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments.

A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.

Use of proteomic patterns in serum to identify ovarian cancer.

P304

647-653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14622416.6.6.647

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16143004

http://www.w3.org/2001/XMLSchema#string

P921